Click Here to return To Results

 

Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease JNNP 76:1624-1629, Masse,I.,et al, 2005 See this aricle in Pubmed Article Abstract LLAs may slow cognitive decline in Alzheimers disease and have a neuroprotective effect. This should be confirmed by placebo controlled randomized trials in patients with Alzheimers disease and no dyslipaemia.

Related Tags

(click to filter results - removes previous filter) Alzheimer's disease Alzheimer's disease,treatment of dementia,prevention of dementia,treatment of lipid lowering agent Mini Mental Status Examination prevention of neurologic disorders statin therapy treatment of neurologic disorder

Click Here to return To Results